Swedbank Ab Sarepta Therapeutics, Inc. Transaction History

Swedbank Ab

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Dec 09, 2024	SELL	$67.31 - $124.76 $2.78 Million - $5.15 Million	-41,245 Closed	0 $0
Q2 2022 Dec 09, 2024	BUY	$62.69 - $88.44 $100,304 - $141,504	1,600 Added 4.04%	41,245 $3.09 Million
Q1 2022 Dec 09, 2024	BUY	$63.15 - $90.42 $981,666 - $1.41 Million	15,545 Added 64.5%	39,645 $3.1 Million
Q2 2021 Dec 09, 2024	SELL	$69.38 - $86.75 $291,257 - $364,176	-4,198 Reduced 14.83%	24,100 $1.87 Million
Q1 2021 Dec 09, 2024	BUY	$72.25 - $168.95 $2.04 Million - $4.78 Million	28,298 New	28,298 $2.11 Million

530

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Swedbank Ab, based on Form 13F filings with the SEC.

Stay updated on Swedbank Ab with notifications on news.